See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2013_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 894,505 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,413,755 |
| 2 | PropertyPlantAndEquipmentNet | 78,068 |
| 3 | remainder_Assets | 429,469 |
| 4 | LiabilitiesCurrent | 9,339,582 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 438,939 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,688,677 |
| 9 | ResearchAndDevelopmentExpense | 6,646,094 |
| 10 | remainder_Expenses | 4,189,741 |
| 11 | remainder_Revenues | 12,002 |
| 12 | remainder_NetIncome | 4,442,823 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,815,797 |
| 1 | Liabilities | 9,778,521 |
| 2 | Expenses | 16,524,512 |
| 3 | Revenues | 12,002 |
| 4 | StockholdersEquity | -5,962,724 |
| 5 | NetIncome | -12,069,687 |
| 6 | ComprehensiveNetIncome | -12,069,687 |
| 7 | BaseVar | 17,286,828 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.69 |
| 9 | EconomicCapitalRatio | 0.475 |
Edgar->Model Mapping
Feature Distribution
